Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway

Abstract Approximately, 25% of nasopharyngeal carcinoma (NPC) patients develop recurrent disease. NPC may involve relatively few genomic alterations compared to other cancers due to its association with Epstein‐Barr virus (EBV). We envisioned that in‐depth sequencing of tumor tissues might provide n...

Full description

Bibliographic Details
Main Authors: An‐Ko Chung, Chun‐Nan OuYang, Hsuan Liu, Mei Chao, Ji‐Dung Luo, Cheng‐Yang Lee, Yen‐Jung Lu, I‐Che Chung, Lih‐Chyang Chen, Shao‐Min Wu, Ngan‐Ming Tsang, Kai‐Ping Chang, Cheng‐Lung Hsu, Hsin‐Pai Li, Yu‐Sun Chang
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2429
id doaj-f8ef00ee3b1f461d9a6f56fe509e7a7e
record_format Article
spelling doaj-f8ef00ee3b1f461d9a6f56fe509e7a7e2020-11-24T21:23:59ZengWileyCancer Medicine2045-76342019-09-018115116512710.1002/cam4.2429Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathwayAn‐Ko Chung0Chun‐Nan OuYang1Hsuan Liu2Mei Chao3Ji‐Dung Luo4Cheng‐Yang Lee5Yen‐Jung Lu6I‐Che Chung7Lih‐Chyang Chen8Shao‐Min Wu9Ngan‐Ming Tsang10Kai‐Ping Chang11Cheng‐Lung Hsu12Hsin‐Pai Li13Yu‐Sun Chang14Graduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaMolecular Medicine Research Center Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaMolecular Medicine Research Center Chang Gung University Taoyuan City Taiwan, Republic of ChinaResearch Information Session, Office of Information Technology Taipei Medical University Taipei City Taiwan, Republic of ChinaACT Genomics, Co. Ltd. Taipei City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaDepartment of Medicine Mackay Medical College New Taipei City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaDepartment of Radiation Chang Gung Memorial Hospital Chang Gung University Taoyuan City Taiwan, Republic of ChinaDepartment of Otolaryngology‐Head and Neck Surgery Chang Gung Memorial Hospital Chang Gung University Taoyuan City Taiwan, Republic of ChinaDivision of Hematology‐Oncology, Department of Internal Medicine Chang Gung Memorial Hospital Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaAbstract Approximately, 25% of nasopharyngeal carcinoma (NPC) patients develop recurrent disease. NPC may involve relatively few genomic alterations compared to other cancers due to its association with Epstein‐Barr virus (EBV). We envisioned that in‐depth sequencing of tumor tissues might provide new insights into the genetic alterations of this cancer. Thirty‐three NPC paired tumor/adjacent normal or peripheral blood mononuclear cell samples were deep‐sequenced (>1000×) with respect to a panel of 409 cancer‐related genes. Newly identified mutations and its correlation with clinical outcomes were evaluated. Profiling of somatic mutations and copy number variations (CNV) in NPC tumors identified alterations in RTK/RAS/PI3K, NOTCH, DNA repair, chromatin remodeling, cell cycle, NF‐κB, and TGF‐β pathways. In addition, patients harbored CNV among 409 cancer‐related genes and missense mutations in TGF‐β/SMAD signaling were associated with poor overall survival and poor recurrence‐free survival, respectively. The CNV events were correlated with plasma EBV copies, while mutations in TGFBR2 and SMAD4 abrogate SMAD‐dependent TGF‐β signaling. Functional analysis revealed that the new TGFBR2 kinase domain mutants were incapable of transducing the signal, leading to failure of phosphorylation of SMAD2/3 and activation of downstream TGF‐β‐mediated cell growth arrest. This study provides evidence supporting CNV and dysregulated TGF‐β signaling contributes to exacerbating the NPC pathogenesis.https://doi.org/10.1002/cam4.2429copy number variationmutationnasopharyngeal carcinomanext‐generation sequencingTGF‐β signaling
collection DOAJ
language English
format Article
sources DOAJ
author An‐Ko Chung
Chun‐Nan OuYang
Hsuan Liu
Mei Chao
Ji‐Dung Luo
Cheng‐Yang Lee
Yen‐Jung Lu
I‐Che Chung
Lih‐Chyang Chen
Shao‐Min Wu
Ngan‐Ming Tsang
Kai‐Ping Chang
Cheng‐Lung Hsu
Hsin‐Pai Li
Yu‐Sun Chang
spellingShingle An‐Ko Chung
Chun‐Nan OuYang
Hsuan Liu
Mei Chao
Ji‐Dung Luo
Cheng‐Yang Lee
Yen‐Jung Lu
I‐Che Chung
Lih‐Chyang Chen
Shao‐Min Wu
Ngan‐Ming Tsang
Kai‐Ping Chang
Cheng‐Lung Hsu
Hsin‐Pai Li
Yu‐Sun Chang
Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
Cancer Medicine
copy number variation
mutation
nasopharyngeal carcinoma
next‐generation sequencing
TGF‐β signaling
author_facet An‐Ko Chung
Chun‐Nan OuYang
Hsuan Liu
Mei Chao
Ji‐Dung Luo
Cheng‐Yang Lee
Yen‐Jung Lu
I‐Che Chung
Lih‐Chyang Chen
Shao‐Min Wu
Ngan‐Ming Tsang
Kai‐Ping Chang
Cheng‐Lung Hsu
Hsin‐Pai Li
Yu‐Sun Chang
author_sort An‐Ko Chung
title Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
title_short Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
title_full Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
title_fullStr Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
title_full_unstemmed Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
title_sort targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the tgf‐β pathway
publisher Wiley
series Cancer Medicine
issn 2045-7634
publishDate 2019-09-01
description Abstract Approximately, 25% of nasopharyngeal carcinoma (NPC) patients develop recurrent disease. NPC may involve relatively few genomic alterations compared to other cancers due to its association with Epstein‐Barr virus (EBV). We envisioned that in‐depth sequencing of tumor tissues might provide new insights into the genetic alterations of this cancer. Thirty‐three NPC paired tumor/adjacent normal or peripheral blood mononuclear cell samples were deep‐sequenced (>1000×) with respect to a panel of 409 cancer‐related genes. Newly identified mutations and its correlation with clinical outcomes were evaluated. Profiling of somatic mutations and copy number variations (CNV) in NPC tumors identified alterations in RTK/RAS/PI3K, NOTCH, DNA repair, chromatin remodeling, cell cycle, NF‐κB, and TGF‐β pathways. In addition, patients harbored CNV among 409 cancer‐related genes and missense mutations in TGF‐β/SMAD signaling were associated with poor overall survival and poor recurrence‐free survival, respectively. The CNV events were correlated with plasma EBV copies, while mutations in TGFBR2 and SMAD4 abrogate SMAD‐dependent TGF‐β signaling. Functional analysis revealed that the new TGFBR2 kinase domain mutants were incapable of transducing the signal, leading to failure of phosphorylation of SMAD2/3 and activation of downstream TGF‐β‐mediated cell growth arrest. This study provides evidence supporting CNV and dysregulated TGF‐β signaling contributes to exacerbating the NPC pathogenesis.
topic copy number variation
mutation
nasopharyngeal carcinoma
next‐generation sequencing
TGF‐β signaling
url https://doi.org/10.1002/cam4.2429
work_keys_str_mv AT ankochung targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT chunnanouyang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT hsuanliu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT meichao targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT jidungluo targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT chengyanglee targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT yenjunglu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT ichechung targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT lihchyangchen targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT shaominwu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT nganmingtsang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT kaipingchang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT chenglunghsu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT hsinpaili targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
AT yusunchang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway
_version_ 1725990177567932416